Achromatopsia

  • Jun 26, 2018 globenewswire.com
    MeiraGTx Receives Positive Opinion for Orphan Drug Designation in the European Union for AAV-CNGA3 for the Treatment of Achromatopsia – GlobeNewswire
    Read More
  • Jun 01, 2018 seekingalpha.com
    MeiraGTx Files To Raise $75 Million In IPO – Seeking Alpha
    Read More
  • Jun 01, 2018 www.stuff.co.nz
    Blind and bullied, now a bestselling author: Steff Green’s next book is personal – Stuff.co.nz
    Read More
  • May 15, 2018 www.fiercebiotech.com
    Gene therapy startup MeiraGTx files for $86M IPO – FierceBiotech
    Read More
  • May 11, 2018 seekingalpha.com
    Applied Genetic Technologies’ (AGTC) CEO Sue Washer on Q3 2018 Results – Earnings Call Transcript – Seeking Alpha
    Read More
  • Apr 10, 2018 globenewswire.com
    AGTC Announces Completion of Enrollment of Phase 1 / 2 Clinical Study of Investigational Gene Therapy in Patients with X-linked Retinoschisis (XLRS) – GlobeNewswire
    Read More
  • Mar 16, 2018 www.healio.com
    Diagnosis and Treatment Options for Achromatopsia: A Review of the Literature – Healio
    Read More
  • Mar 05, 2018 www.thedartmouth.com
    One-on-one with Staci Mannella ’18 – The Dartmouth
    Read More
  • Mar 02, 2018 www.businesswire.com
    MeiraGTx Receives EMA PRIME Designation for Achromatopsia Gene Therapy Candidate – Business Wire
    Read More

Connect. Empower. Inspire.